Olivier Zitoun, Partner, Life Sciences Practices Lead at Capgemini Invent
Determining “what’s next?” is a question that is becoming increasingly difficult for life sciences organizations to answer. New therapies, business models, disruptive technologies, and market access challenges are transforming all aspects of the patient journey.
In September 2018, Capgemini introduced a new global group, Capgemini Invent, that focuses specifically on helping clients answer the question of “what’s next?” through digital transformation and innovation offerings. By combining strategy, technology, data science, and creative design expertise with an inventive mindset, Capgemini Invent works with clients to solve their most complex business and technology challenges.
With more than 6,000 people across 30 offices globally and 10 studios, Capgemini Invent represents a new generation of consultancy. Through advanced analytics capabilities (AI/ML) and breakthrough technologies (blockchain, AR/VR), Capgemini Invent can enable the transformation of clinical trials, achieve commercial excellence, and deliver insight-powered patient and HCP engagement.
Capgemini Invent offers a unique model for digital transformation delivery with six integrated practices:
- Innovation and Strategy
- Patient & HCP Engagement
- People and Organization
- Operations Transformation
- Insight Driven Enterprise
- Future of Technology
These six practices can help the largest enterprises move quickly from strategic thinking and recommendations to development and operation of groundbreaking ideas at global scale.